a decreasing trendp > 0.05
Furthermore, there was a decreasing trend of AST in T2DM with DR (21.5 ± 8.8 U/L vs. 23.9 ± 18.7 U/L, p > 0.05) and T2DM with nephropathy (21.5 ± 9.9 U/L vs. 23.9 ± 18.7 U/L, p > 0.05) compared to T2DM patients without either of them, despite the nonsignificant results [ 10 ].